anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Compass Therapeutics · pitchdeck

Compass Therapeutics | IPO Presentation Deck | 40 slides

40 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Compass Therapeutics | IPO Presentation Deck | 40 slides

Compass Therapeutics · 2020-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 26 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits Solution 18 slides 100% 18/18 slides 100% 18/18 slides · 78 hits
— 0/18 slides
50% 9/18 slides 27.8% 5/18 slides 100% 18/18 slides · 24 hits 100% 18/18 slides Product 6 slides 100% 6/6 slides 100% 6/6 slides · 29 hits
— 0/6 slides
83.3% 5/6 slides 33.3% 2/6 slides 100% 6/6 slides · 12 hits 100% 6/6 slides Team 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides

Slide inventory

40
every slide · same image gating as the playbook
01
Slide 1
Includes company logo and a scientific illustration of a protein structure.front_matter
Open slide detail
02
other
Open slide detail
03
summarize
Open slide detail
04
summarize
Open slide detailLoop · Golden Circle
05
Includes logos for both team affiliations and investor base.other
Open slide detailBeat · TeamLoop · Golden Circle
06
show_traction
Open slide detailLoop · Golden Circle
07
The slide highlights technical capabilities and productivity metrics at the bottom.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
08
The slide uses a biological interaction map to demonstrate the breadth of the company's target library.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
09
The slide shows a workflow from a 'toolbox of validated leads' to 'high-throughput expression & characterization' and finally to specific multi-specific construpresent_solution
Open slide detailBeat · SolutionLoop · Golden Circle
10
The slide uses a Gantt-style chart to show the progress of four distinct programs.plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
11
The slide uses a timeline framework to track progress of four distinct programs (CTX-471 monotherapy, CTX-471 combo, CTX-8371, and NKp30 platform) plus future pplan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
12
present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
13
The slide uses a molecular structure diagram to illustrate the binding site differences between CTX-471 and existing therapies.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
14
The slide uses a before-after-bridge style framing to highlight the drug's superior efficacy compared to standard monotherapies.show_traction
Open slide detailBeat · SolutionLoop · Golden Circle
15
The slide uses a series of line charts to demonstrate efficacy across different antibody affinities.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
16
The slide compares initial monotherapy survival against a re-challenge survival study.show_traction
Open slide detailBeat · SolutionLoop · Golden Circle
17
The diagram shows a multi-step process involving opsonization, NK cells, macrophages, dendritic cells (DC), and T-cell activation via CD137.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
18
The slide uses a series of small-multiple line charts to show tumor growth over time and a Kaplan-Meier survival curve to show efficacy.show_traction
Open slide detailBeat · SolutionLoop · Golden Circle
19
The slide includes a Kaplan-Meier plot showing PFS outcomes for different patient cohorts (PD-1 refractory, immune competent).plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
20
Includes a pharmacokinetic simulation graph and a conceptual dose-response curve illustrating that maximal receptor occupancy may not correlate with optimal bioanalyze_data
Open slide detailBeat · SolutionLoop · Golden Circle
21
The slide presents two distinct tables: one for patient demographics/clinical history and one for cancer indications.analyze_data
Open slide detailBeat · SolutionLoop · Golden Circle
22
The slide uses red arrows for primary categories and blue arrows for sub-points.analyze_data
Open slide detailBeat · SolutionLoop · Golden Circle
23
Includes CT scan imagery as evidence of efficacy.show_traction
Open slide detailBeat · SolutionLoop · Golden Circle
24
Clinical trial update slide.show_traction
Open slide detailBeat · SolutionLoop · Golden Circle
25
The slide uses a flow-chart structure to segment the patient population and map them to specific therapeutic regimens across 1st line, maintenance, and 2nd linepresent_framework
Open slide detailBeat · ProblemLoop · Cost Of Inaction
26
transition
Open slide detailLoop · Golden Circle
27
present_solution
Open slide detailLoop · Golden Circle
28
The slide uses a process flow to show the transition from screening to hypothesis testing and final validation.present_solution
Open slide detailLoop · Golden Circle
29
The slide presents two distinct experimental results: a western blot for PD-1 and a line graph for CD28-His-APC binding.present_solution
Open slide detailLoop · Golden Circle
30
The slide uses a biological diagram to contrast the efficacy of standard PD-1 inhibitors versus the proprietary CTX-8371 molecule.present_solution
Open slide detailLoop · Golden Circle
31
Includes individual tumor growth curves, average tumor volume at day 15, and Kaplan-Meier survival curves.show_traction
Open slide detailLoop · Golden Circle
32
The slide uses a nested bulleted list to organize technical and strategic milestones.summarize
Open slide detailLoop · Golden Circle
33
The slide uses a solid red background with a subtle geometric pattern in the top right corner.transition
Open slide detailLoop · Golden Circle
34
Shows a scientific workflow from discovery to primary and secondary screening.present_framework
Open slide detailLoop · Golden Circle
35
The slide shows dose-response curves for specific lysis of tumor cells, highlighting the potency of NKp30-based bispecifics.present_solution
Open slide detailLoop · Golden Circle
36
Includes survival curve (Kaplan-Meier) and IgM depletion bar chart.show_traction
Open slide detailLoop · Golden Circle
37
The table uses a green/red color coding to highlight the competitive advantage of the company's lead asset.compare_peers
Open slide detailLoop · Golden Circle
38
The slide outlines a dual-track strategy: oncology (solid tumors) and autoimmune diseases.present_solution
Open slide detailLoop · Golden Circle
39
transition
Open slide detailLoop · Golden Circle
40
Uses a combination of checkmarks for completed items and stars for in-progress/future items.show_traction
Open slide detailLoop · Golden Circle